Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TEIPP24 |
Synonyms | |
Therapy Description |
Limited information is currently available for TEIPP24, a putative synthetic long peptide vaccine (Jan 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TEIPP24 | LRPAP7-30V-SLP vaccine | Limited information is currently available for TEIPP24, a putative synthetic long peptide vaccine (Jan 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05898763 | Phase Ib/II | Pembrolizumab + TEIPP24 TEIPP24 | TEIPP Immunotherapy in Patients With NSCLC | Completed | NLD | 0 |